UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033926
Receipt number R000038375
Scientific Title The effects of walking through apertures training in individuals with stroke: a randomized controlled trial
Date of disclosure of the study information 2018/09/01
Last modified on 2023/03/01 11:39:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of walking through apertures training in individuals with stroke: a randomized controlled trial

Acronym

The effects of walking through apertures training in individuals with stroke

Scientific Title

The effects of walking through apertures training in individuals with stroke: a randomized controlled trial

Scientific Title:Acronym

The effects of walking through apertures training in individuals with stroke

Region

Japan


Condition

Condition

Stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate whether obstacle avoidance training that passing through a narrow aperture from the paretic side contributes to the improvement of contact rate, walking ability, and balance ability for the stroke patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The mean percentage of contacts with the frame of an aperture (The timing of the measurement is before and after the intervention)

Key secondary outcomes

The following assessment excluding the falls incident is carried out before and after the intervention.
10m walking test (10MWT)
Timed up and Go Test (TUG)
Berg Blance Scale (BBS)
Activities-specific Balance Confidence (ABC) Scale
Walking speed and trunk rotation angle at the time of passage
Falls incident after six months


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

In the intervention group, participants through a narrow aperture (0.9, 1.0.1.1, 1.2 times of their shoulder width) in the walking path of 5 m, five times a week for 40 minutes. If they decide that it is necessary to rotate, they penetrate an aperture from the paretic side.

Interventions/Control_2

In the control group, participants walk through a sufficiently wide width (180 cm) without rotation at the same place, distance and duration as the intervention group.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Participants were patients in a subacute hospital and they had residual hemiparesis.
The inclusion criteria ensured that participants had been walking for at least one month after a first-time stroke and that they were able to walk independently for more than 100 m with or without an assistive device.

Key exclusion criteria

The exclusion criteria ensured that none of the participants had any indications of the following symptoms: (a) neurological, orthopedic, or other disorders that could affect walking, (b) history of visual deficits, (c) visual field deficits and visual spatial neglect, and (d) a score of less than 24 on the Mini Mental State Examination (MMSE)

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Muroi

Organization

Kameda Rehabilitation Hospital

Division name

Department of Rehabilitation

Zip code

296-0041

Address

975-2 Higashicho, Kamogawa, Chiba 296-8602, Japan

TEL

04-7093-1400

Email

mutyon88@hotmail.com


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Muroi

Organization

Kameda Rehabilitation Hospital

Division name

Department of Rehabilitation

Zip code

296-0041

Address

975-2 Higashicho, Kamogawa, Chiba 296-8602, Japan

TEL

04-7093-1400

Homepage URL


Email

mutyon88@hotmail.com


Sponsor or person

Institute

Kameda Medical Center

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science (KAKENHI Grant Number 19K19845 [Daisuke Muroi]

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kameda General Hospital

Address

929 Higashi-cho Kamogawa Chiba, Japan

Tel

04-7092-2211

Email

muroi.daisuke@kameda.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

亀田リハビリテーション病院(千葉県)


Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

38

Results

Collision rate and time to passage of the opening in obstacle avoidance task significantly improved in the T-WTO group compared with those in the R-Control group. Contrastingly, T-WTO did not lead to significant improvements in other outcomes.

Results date posted

2021 Year 08 Month 30 Day

Results Delayed

Delay expected

Results Delay Reason

under review

Date of the first journal publication of results

2022 Year 12 Month 31 Day

Baseline Characteristics


Participant flow


Adverse events

None

Outcome measures

The following assessment excluding the falls incident is carried out before and after the intervention.
10m walking test (10MWT)
Timed up and Go Test (TUG)
Berg Blance Scale (BBS)
Activities-specific Balance Confidence (ABC) Scale
Walking speed at the time of passage
Falls incident after six months

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2018 Year 08 Month 14 Day

Date of IRB

2018 Year 08 Month 28 Day

Anticipated trial start date

2018 Year 08 Month 28 Day

Last follow-up date

2021 Year 06 Month 30 Day

Date of closure to data entry

2021 Year 07 Month 31 Day

Date trial data considered complete

2021 Year 07 Month 31 Day

Date analysis concluded

2022 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2018 Year 08 Month 28 Day

Last modified on

2023 Year 03 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038375


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name